Condition
Castrate Resistant Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Castrate Resistant Prostate Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Italy (1)). By phase: Phase 1/2 (2), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Castrate Resistant Prostate Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| DR-0202 for advanced, relapsed, or treatment-resistant carcinomas | Phase 1 | Denver, Colorado and 9 other locations | Recruiting | May 31, 2025 |
| Using Olaparib for Advanced Prostate Cancer | — | Naples and 1 other locations | Recruiting | Jan 20, 2025 |
| Testing a new drug ETX-19477 for advanced solid tumors | Phase 1/2 | Phoenix, Arizona and 13 other locations | Recruiting | May 2, 2024 |
| Combining pembrolizumab with targeted radionuclide therapy for advanced prostate cancer | Phase 2 | San Francisco, California | Recruiting | Mar 13, 2023 |
| Evaluating TT-10 and TT-4 for advanced solid tumors | Phase 1/2 | Los Angeles, California and 1 other locations | Recruiting | Jul 20, 2021 |
All recruiting trials (5)
-
DR-0202 for advanced, relapsed, or treatment-resistant carcinomas
This trial tests DR-0202 in adults with advanced or metastatic carcinomas—such as certain breast, lung, cervical, and prostate cancers—that have relapsed or stopped responding to standard treatments.
-
Using Olaparib for Advanced Prostate Cancer
This study is testing how well the drug olaparib works for men with advanced prostate cancer who have specific genetic changes, to see if it helps them live longer and feel better.
-
Testing a new drug ETX-19477 for advanced solid tumors
This study is testing a new drug called ETX-19477 to see if it can help people with advanced solid tumors that haven't responded to other treatments.
-
Combining pembrolizumab with targeted radionuclide therapy for advanced prostate cancer
This study is testing if combining pembrolizumab with a targeted radiation treatment can help men with advanced prostate cancer live longer and feel better after other treatments have stopped working.
-
Evaluating TT-10 and TT-4 for advanced solid tumors
This study is testing two new drugs, TT-10 and TT-4, to see if they are safe and effective for people with advanced solid tumors who haven't had success with other treatments.
Related topics
Quick answers
How many Castrate Resistant Prostate Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.